The ESTRO 2026 presentation by Dr. Adam Raben reports that 958 patients viewing personalized AI-avatar videos scored higher on treatment understanding, decision engagement, and satisfaction than 506 peers given standard videos, with all 1,464 completing post-viewing quizzes. This comparative study, however, lacks randomization details and remains a conference abstract rather than peer-reviewed RCT, limiting causal claims. Building on a 2023 observational cohort in JCO Clinical Cancer Informatics (n=1,200) that linked digital pre-education to 22% lower anxiety scores, and a 2024 multicenter RCT in Radiotherapy and Oncology (n=890) showing chatbot-assisted consent improved retention without increasing consultation time, the findings point to scalable hybrid models that address information overload in radiation oncology. Missed in coverage is the risk of digital exclusion for elderly or low-literacy subgroups and potential over-reliance on scripted content that may not adapt to cultural nuances. No conflicts were declared, yet industry partnership with the avatar developer warrants scrutiny in future work. Overall, the approach aligns with emerging evidence that pre-consult AI can streamline informed consent while freeing clinicians for personalized dialogue.